phototoxic dermatitis: a form of allergic contact dermatitis in which the allergen must be activated by light to sensitize the allergic response, and to cause a rash or other systemic effects on subsequent exposure. The second and subsequent exposures produce photoallergic skin conditions which are often eczematous. In rare cases the victims die.
Other and unspecified skin changes due to chronic exposure to nonionizing radiation
DOID EFO Endpoint Browser PheWeb
L12_NONIONRADISKINNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
458 |
4. Check minimum number of eventsNone |
458 |
5. Include endpointsNone |
458 |
6. Filter based on genotype QC (FinnGen only) |
458 |
Control definitions (FinnGen only)
- Control exclude
- L12_RADIATIONRELATEDSKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified skin changes due to chronic exposure to nonionizing radiation
based on the number of shared cases.
Similar with more cases:
- Skin changes due to chronic exposure to nonionizing radiation
- Radiation-related disorders of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3420 | 1992 | 1406 |
| Only index persons | 3066 | 1831 | 1235 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 71.86 | 71.91 | 71.77 |
| Only index persons | 71.03 | 71.15 | 70.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 458 | 235 | 223 |
| Unadjusted period prevalence (%) | 0.09 | 0.08 | 0.10 |
| Median age at first event (years) | 67.92 | 66.13 | 69.80 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 427
- Matched controls
- 4271
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
3120.7
300.6
255
*
L57.0
ICD-10 Finland
Actinic keratosis
83.4
238.9
264
81
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
3326.5
208.1
184
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
21.6
125.5
199
166
ZXC50
NOMESCO Finland
Cryotherapy
131.9
96.9
101
10
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
97.2
85.2
92
12
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
58.9
76.4
89
19
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
223.0
73.7
74
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.1
64.3
141
198
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
11.2
58.7
119
142
TQW99
NOMESCO Finland
Other minor procedure on skin
16.3
52.8
88
67
ZXC15
NOMESCO Finland
Use of photodynamic technique
175.5
45.8
47
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
46.2
43.7
53
13
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
10.0
43.0
91
113
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
49.0
40.0
48
11
D06BB10
ATC
imiquimod; topical
12.9
38.4
70
64
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
21.0
35.0
52
28
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
34.0
33.3
43
14
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
10.6
32.0
64
70
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.3
28.7
122
361
XQ845
NOMESCO Finland
Dermatoscopy
26.9
27.1
37
15
XQ848
NOMESCO Finland
Dermatological photography
17.8
26.9
42
26
E0000UV
ATC
NA
3.1
26.3
215
1055
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
11.3
24.7
47
46
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
92.1
23.9
26
*
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
+∞
22.1
21
*
SPAT1153
SPAT
Removal of sutures
2.8
20.5
190
963
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.4
20.4
114
412
TEA00
NOMESCO Finland
Biopsy of lip
22.9
19.8
28
13
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
42.3
19.7
24
6
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.2
19.1
62
135
ZZR00
NOMESCO Finland
Flap of skin
10.6
19.0
37
38
EAA10
NOMESCO Finland
Excision of lesion of lip
17.5
18.1
28
17
D07AB02
ATC
hydrocortisone butyrate; topical
2.7
17.8
157
756
ZXC20
NOMESCO Finland
Use of chemical agents
11.4
17.8
33
31
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
52.3
17.1
20
*
E000001
ATC
NA
2.9
16.9
118
492
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
14.2
16.7
28
21
L82
ICD-10 Finland
Seborrhoeic keratosis
3.2
16.6
100
377
S18
ICPC
Laceration/cut
2.4
16.5
213
1250
D07AB08
ATC
desonide; topical
3.6
15.8
77
247
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
+∞
15.7
15
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
10.0
15.7
31
33
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
165.8
15.6
16
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
9.5
15.2
31
35
D07AC13
ATC
mometasone; topical
2.5
15.2
151
765
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
83.0
14.7
16
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
83.0
14.7
16
*
D07AC01
ATC
betamethasone; topical
2.4
14.5
173
959
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
28.3
14.4
19
7
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
12.6
14.3
25
21
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
9.1
14.0
29
34
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
14.2
13.9
23
17
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
13.6
13
*
ZXC07
NOMESCO Finland
Carbon dioxide laser
+∞
13.6
13
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
35.3
13.6
17
5
K13.03
ICD-10 Finland
Keilit UNS
144.4
13.5
14
*
D07AA02
ATC
hydrocortisone; topical
3.2
13.3
77
277
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
41.5
13.2
16
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
51.7
12.9
15
*
D06BX02
ATC
ingenol mebutate; topical
14.7
12.9
21
15
L56.4
ICD-10 Finland
Polymorphous light eruption
72.1
12.7
14
*
EAA30
NOMESCO Finland
Partial excision of lower lip
133.8
12.5
13
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
133.8
12.5
13
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
133.8
12.5
13
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
11.4
41
100
ZQZ00
NOMESCO Finland
Treatment of several skin areas
36.1
11.3
14
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
22.1
10.7
15
7
P01BA02
ATC
hydroxychloroquine; oral
3.4
10.7
52
165
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.5
10.5
50
157
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
+∞
10.5
10
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
33.4
10.4
13
*
E000002
ATC
NA
2.9
10.1
62
233
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
15.1
10.1
16
11
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
41.1
10.0
12
*
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
41.1
10.0
12
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.8
9.8
27
49
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
30.8
9.4
12
*
A02BC05
ATC
esomeprazole; systemic
1.9
9.4
187
1229
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
9.3
68
284
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.3
9.3
47
155
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
16.0
9.1
14
9
DHB00
NOMESCO Finland
Excision of lesion of external nose
12.9
8.9
15
12
XQ802
NOMESCO Finland
Epicutan test
6.0
8.7
23
40
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
28.1
8.5
11
*
L56.9
ICD-10 Finland
Acute skin change due to ultraviolet radiation, unspecified
91.8
8.4
9
*
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
91.8
8.4
9
*
J01DB01
ATC
cefalexin; oral
2.0
8.3
334
2752
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.2
213
1510
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
12.0
8.1
14
12
S29
ICPC
Skin symptom/complaint other
2.2
8.1
85
427
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
34.0
8.1
10
*
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
34.0
8.1
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
7.8
72
340
B07.9
ICD-10 Finland
Verruca simplex
6.1
7.8
20
34
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
7.8
189
1307
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.0
7.7
30
80
ZXC10
NOMESCO Finland
Use of laser
5.9
7.6
20
35
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
25.5
7.6
10
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
7.6
295
2357
S21
ICPC
Skin texture symptom/complaint
2.4
7.4
62
279
J05AB01
ATC
aciclovir; systemic
2.1
7.3
95
522
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
7.3
49
192
K13.09
ICD-10 Finland
Disease of the lips UNS
+∞
7.3
7
*
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
+∞
7.3
7
*
XF404
NOMESCO Finland
Ambulatory ECG
2.6
7.3
55
232
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
7.1
198
1412
DAB00
NOMESCO Finland
Excision of lesion of auricle
10.3
7.1
13
13
D02AX
ATC
Other emollients and protectives
4.6
7.1
23
52
H02AB06
ATC
prednisolone; systemic
1.7
7.0
208
1512
E000007
ATC
NA
3.4
7.0
32
99
L04AA01
ATC
[U] ciclosporin; systemic
8.5
6.9
14
17
S08
ICPC
Skin colour change
3.3
6.8
33
106
127
Kela drug reimbursment
Transplant complication
11.2
6.8
12
11
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.6
6.8
50
209
SPAT1301
SPAT
No procedures
1.8
6.8
154
1027
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
17.0
6.8
10
6
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
17.0
6.8
10
6
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
6.7
96
546
WX110
NOMESCO Finland
Local anesthesy
1.7
6.7
253
1963
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
6.7
191
1368
SDA02
NOMESCO Finland
Parodonthologic therapy
1.9
6.7
118
726
S77
ICPC
Malignant neoplasm of skin
8.0
6.7
14
18
L04AD01
ATC
ciclosporin; systemic
8.0
6.7
14
18
ZZA00
NOMESCO Finland
Split skin graft
3.8
6.6
26
71
SPAT1325
SPAT
Vaccination
1.7
6.6
178
1251
ZXE00
NOMESCO Finland
One hour or less
1.7
6.5
167
1154
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
70.9
6.4
7
*
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
70.9
6.4
7
*
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.3
6.4
58
270
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
6.4
34
118
TQW80
NOMESCO Finland
Local dermatologic skincare
5.7
6.4
17
31
SPAT1263
SPAT
Sampling
1.7
6.3
183
1306
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
11.3
6.3
11
10
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
6.3
109
664
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
6.3
50
219
L30.3
ICD-10 Finland
Infective dermatitis
3.9
6.2
24
65
L20.0
ICD-10 Finland
Besnier prurigo
4.0
6.2
23
60
D05BB02
ATC
acitretin; oral
5.0
6.1
18
37
C10AA01
ATC
simvastatin; oral
1.7
6.1
233
1792
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.1
6.1
32
110
J02AC01
ATC
fluconazole; systemic
1.8
6.0
137
907
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
243
1321
2.79
25.65
3.9
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
55
141
4.30
19.84
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
104
418
2.93
18.70
1.8
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
79
293
3.05
16.25
6.0
3.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
96
405
2.73
15.55
5.0
3.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
90
402
2.54
12.84
1.4
1.3
titre
579.2
439.2
0.37
25
103
(42870588) Differential panel, method unspecified - Blood
192
1189
2.06
12.37
6.6
5.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
329
2500
2.12
11.73
5.8
4.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
248
1731
1.94
10.93
6.6
5.2
e9/l
0.0
0.0
0.23
221
1488
(3013115) Eosinophils [#/volume] in Blood
253
1788
1.93
10.63
6.6
5.4
e9/l
0.2
0.2
0.50
224
1554
(3019198) Lymphocytes [#/volume] in Blood
249
1755
1.92
10.50
6.8
5.3
e9/l
1.8
1.9
0.31
223
1538
(3001604) Monocytes [#/volume] in Blood
245
1718
1.92
10.50
6.6
5.2
e9/l
0.6
0.6
0.38
220
1470
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
408
3459
2.64
10.07
21.8
17.1
mg/l
23.6
26.1
0.79
336
2839
(3013707) Erythrocyte sedimentation rate by Westergren method
336
2654
2.00
9.68
5.0
4.2
mm/h
17.0
14.5
1.79
309
2410
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
352
2832
2.05
9.54
9.2
7.5
u/l
79.5
80.1
0.09
336
2630
(3021440) Promyelocytes/100 leukocytes in Blood
64
279
2.50
9.49
3.8
4.0
%
0.1
0.1
0.39
15
97
(3013650) Neutrophils [#/volume] in Blood by Automated count
273
2022
1.87
9.48
8.6
8.8
e9/l
4.1
4.3
0.64
245
1772
(3013826) Glucose [Moles/volume] in Serum or Plasma
298
2271
1.89
9.44
5.2
4.6
mmol/l
6.9
6.8
0.30
272
2127
(3018010) Neutrophils/100 leukocytes in Blood
232
1635
1.85
9.44
6.8
5.3
%
57.9
58.4
0.28
214
1523
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
330
2604
1.96
9.35
4.3
3.9
pmol/l
15.0
15.1
0.06
291
2300
(3022096) Basophils/100 leukocytes in Blood
226
1584
1.84
9.32
7.2
5.3
%
0.7
0.6
0.59
209
1470
(3041096) Erythrocytes [Presence] in Urine by Automated
153
949
1.92
9.25
4.6
3.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
60
259
2.52
9.08
3.7
4.0
%
0.4
0.4
0.05
15
79
(3006504) Eosinophils/100 leukocytes in Blood
229
1624
1.82
8.98
7.2
5.3
%
3.2
2.9
1.01
212
1507
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
108
3.32
8.97
1.8
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
230
1634
1.82
8.96
7.4
5.6
%
9.3
8.8
1.53
214
1522
(3025159) Blasts/100 leukocytes in Blood
60
263
2.47
8.78
3.9
4.1
%
0.0
1.2
0.56
14
82
(3002030) Lymphocytes/100 leukocytes in Blood
232
1664
1.80
8.66
7.5
5.6
%
27.1
26.2
0.54
215
1536
(40760892) CBC W Ordered Manual Differential panel - Blood
117
676
1.98
8.64
5.1
4.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
57
4.20
8.62
4.1
2.8
%
63.8
59.8
0.68
23
57
(3029937) Albumin [Presence] in Urine by Test strip
152
965
1.86
8.42
4.8
4.4
estimate
0.0
0.0
0.00
73
294
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
54
4.23
8.35
4.1
2.3
e9/l
4.8
4.4
0.33
22
54
(3017181) Myelocytes/100 leukocytes in Blood
64
297
2.34
8.26
3.9
4.0
%
0.6
0.8
0.38
16
104
(3019550) Sodium [Moles/volume] in Serum or Plasma
415
3638
2.50
7.90
25.3
20.5
mmol/l
139.4
139.6
0.94
405
3526
(3024561) Albumin [Mass/volume] in Serum or Plasma
239
1765
1.74
7.77
5.8
4.5
g/l
34.7
34.6
0.12
217
1639
(3023103) Potassium [Moles/volume] in Serum or Plasma
415
3645
2.48
7.74
26.0
20.5
mmol/l
4.0
4.0
0.15
403
3533
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
376
3185
2.01
7.60
5.3
4.8
mu/l
2.0
2.0
0.03
338
2834
(3021589) Normoblasts [#/volume] in Blood
210
1509
1.72
7.43
15.8
10.0
e9/l
0.0
0.0
0.61
189
1234
(3044889) 12 lead EKG panel
314
2543
1.75
6.98
5.3
4.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
379
3253
1.96
6.89
7.6
6.5
mmol/mol
40.8
41.0
0.10
345
2973
(3002385) Erythrocyte distribution width [Ratio]
332
2739
1.77
6.83
26.4
21.1
%
14.0
14.0
0.37
327
2687
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
171
1183
1.71
6.80
2.4
2.4
u/l
56.3
56.2
0.01
156
1090
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
19
50
3.92
6.60
1.4
1.7
pg
32.3
32.2
0.03
19
50
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
190
1364
1.67
6.51
4.8
4.4
—
—
—
0
0
(3013512) EKG study
175
1232
1.68
6.44
4.9
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
402
3546
2.09
6.40
23.6
16.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
231
1750
1.65
6.37
4.5
4.1
estimate
0.0
0.0
0.00
71
314
(3021601) Nitrite [Presence] in Urine by Test strip
232
1760
1.64
6.36
5.7
5.6
estimate
0.0
0.0
0.00
70
307
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
63
323
2.10
6.36
5.2
4.0
mmol/l
1.2
1.2
0.02
51
285
(3024731) MCV [Entitic volume]
417
3734
2.30
6.32
32.4
25.0
fl
91.7
91.7
0.10
410
3656
(3007461) Platelets [#/volume] in Blood
417
3734
2.30
6.32
32.5
25.1
e9/l
243.3
240.9
0.29
405
3624
(3035941) MCH [Entitic mass]
417
3735
2.30
6.30
32.4
25.0
pg
30.4
30.4
0.19
410
3656
(3026361) Erythrocytes [#/volume] in Blood
417
3735
2.30
6.30
32.5
25.1
e12/l
4.4
4.4
0.39
403
3608
(3010813) Leukocytes [#/volume] in Blood
417
3735
2.30
6.30
32.6
25.1
e9/l
7.0
6.9
0.39
403
3610
(3000963) Hemoglobin [Mass/volume] in Blood
417
3736
2.30
6.28
32.7
25.3
g/l
131.7
132.0
0.15
410
3653
(3009261) Glucose [Presence] in Urine by Test strip
233
1782
1.63
6.09
4.5
4.1
estimate
0.0
0.0
0.00
74
303
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
390
3425
1.93
5.97
6.1
5.4
mmol/l
2.5
2.6
0.95
350
3072
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
85
498
1.87
5.86
1.2
1.3
u/ml
19.7
15.7
0.13
34
177
(3026782) Osmolality of Urine
127
839
1.71
5.83
3.7
2.9
mosm/kgh2o
520.5
559.9
1.31
113
719
(4035726)
62
329
2.02
5.70
1.3
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
223
1711
1.59
5.59
15.1
10.3
inr
1.3
1.3
0.33
84
456
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
29
4.58
5.54
2.4
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
251
1984
1.59
5.52
3.3
3.1
u/l
45.1
53.8
1.08
234
1798
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
252
1999
1.58
5.42
8.1
6.4
mmol/l
1.2
1.2
0.67
191
1696
(40767503) Oxygen content in Capillary blood by calculation
23
80
2.97
5.27
2.7
2.3
%
17.2
15.2
2.04
14
38
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
364
3173
1.72
5.16
4.8
4.2
mmol/l
1.2
1.2
0.10
320
2811
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
40
3.84
5.13
2.2
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
57
305
1.99
5.12
2.3
1.9
nmol/l
344.3
383.6
0.82
51
274
(3000850) Epithelial cells [#/volume] in Urine
127
865
1.65
5.12
3.3
2.7
e6/l
4.8
4.9
0.05
110
764
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
263
2.06
5.07
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
377
3330
1.75
4.95
5.6
4.7
mmol/l
4.4
4.5
1.11
337
2997
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
197
1499
1.55
4.94
2.4
2.2
nmol/l
81.1
79.3
0.42
178
1290
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
101
2.67
4.89
2.1
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
374
3302
1.72
4.84
5.4
4.6
mmol/l
1.5
1.5
0.35
333
2952
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3630
1.88
4.74
14.6
11.1
u/l
24.2
23.6
0.42
386
3459
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
63
3.10
4.72
2.0
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
248
2000
1.52
4.68
6.4
6.2
umol/l
10.6
12.0
2.13
234
1885
(1761868) Lipid panel - Serum or Plasma
134
947
1.59
4.58
4.0
3.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
380
3386
1.72
4.55
5.7
5.0
mmol/l
6.0
6.1
0.61
338
3022
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
231
1843
1.51
4.53
6.4
5.6
mmol/l
1.2
1.2
1.02
205
1652
(3001122) Ferritin [Mass/volume] in Serum or Plasma
193
1483
1.52
4.53
3.7
2.7
ug/l
134.0
145.6
0.41
178
1341
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
89
2.67
4.37
1.9
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
300
1.91
4.36
1.5
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
84
2.70
4.29
5.0
4.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
654
1.63
4.21
1.3
1.2
u/ml
2.5
1.2
0.33
25
157
(3000494) Fungus identified in Specimen by Culture
69
419
1.76
4.20
1.8
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
127
909
1.55
4.05
1.9
1.7
pmol/l
453.6
439.5
0.23
101
731
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
126
903
1.55
3.99
1.9
1.6
mmol/l
1.2
1.3
0.35
99
745
(3009542) Hematocrit [Volume Fraction] of Blood
337
2954
1.53
3.91
21.0
18.8
%
38.9
38.4
0.34
151
1823
(3042936) Bacteria identified in Isolate by Culture
86
566
1.64
3.89
2.6
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
223
1.97
3.88
2.9
2.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
55
2.98
3.77
2.1
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
133
975
1.51
3.77
3.5
2.8
umol/l
2743.0
10220.7
1.74
115
812
(3010421) pH of Blood
25
109
2.37
3.76
5.7
4.2
ph
7.4
7.4
0.78
20
86
(3018095) Leukocytes [#/volume] in Urine
179
1396
1.46
3.72
4.7
4.0
e6/l
110.8
98.0
0.13
140
1033
(3015377) Calcium [Moles/volume] in Serum or Plasma
180
1408
1.46
3.68
4.0
3.4
mmol/l
2.3
2.3
0.95
155
1204
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
62
2.81
3.62
4.1
3.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
6
10.11
3.50
1.8
1.0
ug/l
11.1
11.4
—
6
6
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
81
539
1.61
3.50
1.2
1.3
iu/ml
53.6
48.5
0.07
21
172
(3007164) IgA [Mass/volume] in Serum or Plasma
87
590
1.59
3.47
1.7
1.5
g/l
2.9
2.6
0.33
56
327
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
88
2.45
3.44
2.0
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
156
1201
1.45
3.41
4.9
3.8
ph
7.4
7.4
0.25
45
220
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
200
1613
1.43
3.40
5.0
4.2
ng/l
56.0
59.5
0.06
152
1259
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
182
1443
1.43
3.40
4.3
3.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
18
5.08
3.38
2.3
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
158
1222
1.45
3.37
2.1
2.1
u/l
135.6
299.6
1.77
142
1141
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
32
3.50
3.35
1.2
1.3
%
35.5
28.1
—
6
23
(3009508) Creatinine [Moles/volume] in Urine
150
1151
1.45
3.33
3.9
3.0
mmol/l
6.9
6.9
0.02
129
938
(3023520) Reticulocytes [#/volume] in Blood
61
383
1.68
3.30
1.6
2.5
e9/l
66.6
69.9
0.31
48
309
(3004789) Transferrin [Mass/volume] in Serum or Plasma
88
606
1.56
3.29
3.7
2.3
g/l
2.3
2.3
0.07
77
555
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
19
4.81
3.25
2.3
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
55
338
1.71
3.22
1.7
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
69
451
1.62
3.20
2.3
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
77
517
1.59
3.20
1.5
2.5
%
1.7
1.8
0.42
69
456
(3026008) Bacteria identified in Urine by Culture
168
1329
1.42
3.12
4.3
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
155
1209
1.43
3.11
5.0
3.9
mg/mmol
17.7
8.8
0.79
94
755
(3012501) Base excess in Blood by calculation
20
88
2.33
2.98
6.4
4.5
mmol/l
2.8
2.5
0.25
13
57
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
204
1684
1.38
2.90
4.5
4.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
356
3227
1.46
2.89
21.8
16.2
ml/min/173m2
70.9
72.4
0.67
320
2673
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
13
5.45
2.88
4.3
5.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
573
1.53
2.86
3.9
2.4
%
21.5
21.1
0.09
62
497
(3019309) Folate [Moles/volume] in Red Blood Cells
123
935
1.43
2.81
1.9
1.8
nmol/l
1217.9
1178.0
0.17
93
702
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
167
1.92
2.79
1.7
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
197
1627
1.37
2.76
2.7
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
54
345
1.64
2.75
1.8
2.0
ug/g
151.3
133.4
0.16
45
272
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
136
1062
1.40
2.66
2.2
2.2
mg/l
3.4
3.2
0.21
118
906
(3042631) Mycobacterium sp identified in Specimen
14
55
2.59
2.64
4.0
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
156
1.92
2.63
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
60
399
1.58
2.61
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
19
87
2.24
2.61
1.4
1.2
u/ml
2.0
2.3
—
5
14
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
209
1754
1.35
2.60
2.0
2.1
pmol/l
98.1
94.0
0.49
108
908
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
25
3.65
2.58
2.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
144
1140
1.38
2.58
4.0
3.1
mg/l
797.4
169.1
0.62
96
725
(3023419) Bacteria identified in Sputum by Culture
13
50
2.65
2.55
3.0
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
110
834
1.42
2.53
6.1
3.9
ng/l
527.8
284.1
0.35
86
717
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
313
1.63
2.51
1.8
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
27
3.38
2.40
1.6
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
153
1238
1.35
2.37
4.3
3.4
e6/l
100.7
115.0
0.08
130
977
(3003458) Phosphate [Moles/volume] in Serum or Plasma
75
536
1.48
2.35
10.6
4.7
mmol/l
1.1
1.0
0.50
70
487
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
170
1403
1.34
2.29
3.7
3.1
ng/l
2112.3
1833.5
0.28
145
1221
(40768797) Stomach Pathology biopsy report
71
505
1.48
2.28
1.3
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
85
629
1.43
2.23
3.6
3.1
mmol/l
0.8
0.8
1.30
76
588
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
161
1324
1.33
2.21
6.5
5.5
ug/l
2.8
3.0
0.16
138
1155
(3030467) Casts [#/volume] in Urine by Automated count
140
1128
1.35
2.21
3.9
3.3
e6/l
0.6
0.5
0.18
114
864
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
48
2.54
2.20
4.1
4.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
89
667
1.41
2.18
3.7
2.3
umol/l
12.4
12.2
0.06
79
610
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
14
4.33
2.15
8.7
5.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
49
2.49
2.12
1.1
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
1173
1.33
2.10
5.1
4.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
47
313
1.56
2.06
5.6
3.4
ng/l
115.1
87.6
1.22
37
270
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
15
4.04
2.04
1.0
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
19
97
2.00
2.03
1.7
1.8
e6/l
20471.8
16544.4
—
10
69
(3015235) Bicarbonate [Moles/volume] in Capillary blood
22
119
1.89
2.00
4.2
2.8
mmol/l
23.4
25.1
0.52
17
96
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
77
2.12
1.99
1.3
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
12
51
2.39
1.96
1.9
1.7
%
85.8
89.0
0.56
12
51
(3052851) Hemolysis interference index of Serum or Plasma
22
120
1.88
1.96
2.7
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
107
843
1.35
1.93
3.1
3.2
mmol/l
2.5
2.5
0.41
96
735
(3021901) Oxygen saturation in Capillary blood
16
78
2.09
1.93
2.9
2.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
131
1065
1.32
1.92
3.9
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
36
229
1.62
1.91
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
52
2.34
1.89
2.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
113
902
1.34
1.87
6.7
6.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
59
2.24
1.86
2.1
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
154
1.73
1.80
3.3
3.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.36
1.75
1.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.36
1.75
1.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.36
1.75
1.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.36
1.75
1.0
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
32
204
1.61
1.70
2.9
2.0
nmol/l
14.7
12.9
0.47
25
172
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
55
2.21
1.68
2.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
303
1.50
1.68
1.5
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
135
1.74
1.65
2.0
3.7
mg/l
75.6
114.2
0.34
18
108
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
135
1.74
1.65
2.1
3.7
mg/l
46.3
32.0
0.38
18
110
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
49
2.28
1.65
1.8
1.7
nmol/l
57.0
51.3
0.26
11
44
(3049717) Cytology report of Urine Cyto stain
30
191
1.61
1.61
3.3
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
43
2.36
1.61
2.2
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
70
2.03
1.61
1.6
1.6
—
—
—
0
0
(4024509)
8
32
2.53
1.60
1.1
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
20
3.03
1.58
1.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
57
2.14
1.56
1.2
1.6
—
—
—
0
0
(4010399)
37
250
1.52
1.56
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
130
1.73
1.56
2.3
2.4
u/ml
0.4
0.4
0.10
15
71
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
40
275
1.50
1.55
5.2
3.9
kpa
5.1
5.1
0.14
35
250
(3025941) Bacteria identified in Stool by Culture
31
202
1.57
1.53
1.6
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
771
1.31
1.52
1.5
1.7
mg/l
1.1
1.4
0.50
65
611
(3020630) Protein [Mass/volume] in Serum or Plasma
50
363
1.42
1.49
2.3
2.9
g/l
65.3
66.0
0.20
44
322
(4281824)
9
37
2.46
1.48
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
37
2.46
1.48
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
254
1.50
1.46
5.4
4.0
mmol/l
2.6
2.0
0.44
25
194
(3047189) Immunofixation for 24 hour Urine
6
22
2.75
1.44
1.0
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
1.8
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
74
1.92
1.40
1.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
104
1.76
1.39
1.1
1.7
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
1.4
3.1
nmol/l
217.0
160.8
—
5
17
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
68
1.94
1.34
2.1
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
126
1065
1.25
1.33
1.7
1.6
nmol/l
21.1
21.0
0.02
112
884
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
204
1.50
1.26
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
100
1.73
1.25
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
25
2.42
1.24
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
38
272
1.43
1.24
5.4
3.9
ph
7.4
7.4
—
10
27
(3000093) Morphology [Interpretation] in Blood Narrative
8
37
2.18
1.22
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
26
2.32
1.19
2.3
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
6
26
2.32
1.19
1.5
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
311
1.39
1.15
2.2
2.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
36
0.00
1.14
0.0
1.1
—
1.3
—
0
10
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
58
1.92
1.13
1.7
1.4
—
—
—
0
0
(4062490)
7
30
2.35
1.12
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
374
1.35
1.12
1.6
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
96
1.69
1.11
1.9
4.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
104
1.66
1.11
1.2
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
140
0.49
1.11
2.4
4.2
mmol/l
3.7
4.0
—
7
129
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
21
2.40
1.09
9.0
3.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
179
1.48
1.05
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
77
633
1.26
1.04
33.5
26.8
inr
1.4
1.3
—
9
72
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
22
2.29
1.03
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
47
1.93
1.02
1.8
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
131
1.55
1.01
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.0
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
9
49
1.85
0.99
5.3
4.7
mg/l
10.6
12.0
—
9
44
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
165
1.48
0.99
2.1
1.7
g/l
2.8
3.2
0.99
14
128
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
23
2.19
0.98
1.0
1.3
—
11.6
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
116
1.57
0.98
1.3
1.6
—
—
—
0
0
(4268621)
0
29
0.00
0.98
0.0
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
95
808
1.22
0.95
1.5
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
22
150
1.49
0.94
2.2
2.0
g/l
1.4
0.8
0.39
17
129
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
27
2.24
0.93
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
46
359
1.31
0.93
1.8
2.1
g/l
0.2
0.2
0.16
41
330
(3012441) Differential panel - Pleural fluid
9
52
1.75
0.93
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
110
1.57
0.92
1.5
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
6
28
2.16
0.92
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
11
180
0.60
0.88
1.4
3.7
u/ml
17.3
1568.7
—
6
155
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
43
1.88
0.87
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
42
532
0.77
0.87
3.2
6.2
mmol/l
103.7
104.3
0.30
42
519
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
372
1.29
0.87
1.6
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
83
703
1.22
0.87
2.6
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
44
1.83
0.86
1.9
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
44
1.83
0.86
2.3
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
179
1.42
0.86
2.1
1.7
g/l
3.4
3.7
0.32
13
125
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
179
1.42
0.86
2.1
1.7
g/l
7.1
7.6
0.63
14
131
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
179
1.42
0.86
2.1
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
31
1.95
0.84
2.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
31
1.95
0.84
2.3
2.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
45
1.79
0.84
1.9
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
57
1.77
0.84
1.1
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
27
198
1.39
0.82
1.3
1.9
g/l
1.4
1.6
0.54
22
173
(3018677) aPTT in Platelet poor plasma by Coagulation assay
78
663
1.21
0.79
2.0
1.8
s
30.4
29.6
0.43
71
637
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
24
0.00
0.79
0.0
3.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
66
1.68
0.79
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
26
0.00
0.78
0.0
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
123
1092
1.17
0.78
3.2
3.0
u/l
31.2
33.8
0.37
111
1043
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
280
1.31
0.77
2.3
2.8
ml/min/173m2
51.6
57.5
0.49
22
120
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
467
0.77
0.76
3.6
4.4
ug/l
3.1
36.8
1.30
30
404
(3002523) Influenza virus A Ag [Presence] in Specimen
5
24
2.09
0.74
1.4
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
24
2.09
0.74
1.4
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.74
1.0
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
68
1.63
0.72
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
212
1.34
0.72
6.6
8.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.0
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
41
1.72
0.70
1.9
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
135
1218
1.15
0.69
2.5
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
61
1.65
0.69
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
118
0.59
0.68
1.7
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
94
0.53
0.67
1.4
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
16
225
0.70
0.67
4.3
3.7
%
39.6
48.5
0.64
16
220
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
145
1.40
0.67
1.1
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
87
1.51
0.64
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
87
1.51
0.64
1.3
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
71
1.56
0.62
1.5
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
30
1.67
0.61
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
232
0.72
0.61
4.3
3.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
53
1.52
0.58
1.3
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
23
0.00
0.58
0.0
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
274
0.76
0.57
3.1
3.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
426
0.81
0.56
2.8
2.7
umol/l
10.3
9.0
0.09
25
371
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
107
1.42
0.56
4.0
2.8
ug/min
73.5
66.1
—
8
67
(3019150) Specific gravity of Urine by Refractometry
90
803
1.15
0.54
3.9
4.7
kg/l
1.0
1.0
0.23
13
127
(3005570) Glucose [Moles/volume] in Urine
6
38
1.59
0.54
1.2
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
198
1.28
0.50
6.1
4.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
45
1.56
0.49
1.6
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
47
1.50
0.47
1.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
16
120
1.35
0.46
1.1
1.0
—
—
—
0
0
(4034850)
8
117
0.68
0.46
11.5
12.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
49
1.44
0.46
2.3
4.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
50
1.41
0.45
5.9
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
689
0.87
0.45
3.5
2.8
e6/l
1.4
1.1
0.36
41
400
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
31
1.62
0.43
2.2
2.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
32
1.57
0.42
1.8
1.2
—
81.8
—
0
6
(3051651) Icteric interference index of Serum or Plasma
5
32
1.57
0.42
2.2
3.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
57
1.41
0.42
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
59
1.36
0.41
1.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.4
—
219.0
—
0
17
(3005033) Fetal Nuchal fold Thickness US
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.3
—
29.8
—
0
13
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
137
0.72
0.39
1.4
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.8
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
2.2
1.2
—
—
—
0
0
(4146454)
6
43
1.40
0.35
2.8
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
118
1.28
0.34
1.8
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
164
1.23
0.33
1.6
1.7
g/l
10.6
10.2
0.16
14
141
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
47
1.28
0.32
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
45
400
1.14
0.31
2.4
2.6
ug/l
4.6
6.0
0.33
40
342
(3037121) Protein [Mass/volume] in Urine
17
138
1.24
0.31
3.4
3.1
g/l
0.3
0.2
—
7
48
(3019060) Gas panel - Arterial blood
35
306
1.16
0.31
5.5
4.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
121
1.25
0.29
1.6
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
490
1.12
0.28
5.1
4.9
%
34.5
32.3
0.69
40
308
(3024928) Oxygen saturation in Venous blood
11
85
1.30
0.28
3.6
2.0
—
—
—
0
0
(3019225) pH of Specimen
46
416
1.12
0.26
4.6
4.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
39
1.29
0.23
2.2
1.3
nmol/l
0.7
0.6
—
5
34
(3011397) Hemoglobin [Presence] in Urine by Test strip
77
820
0.93
0.22
3.9
4.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
41
1.22
0.22
1.6
1.3
—
—
—
0
0
(44806118)
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(44790049)
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(44790047)
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(44790048)
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.0
—
378.7
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.8
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(4211845)
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
500
1.09
0.21
4.9
6.5
mmol/l
1.4
1.5
0.06
39
395
(3002032) Base excess in Venous blood by calculation
45
413
1.10
0.20
5.5
3.1
mmol/l
1.2
2.1
0.94
33
320
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
80
1.26
0.20
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
48
1.25
0.20
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
48
1.25
0.20
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
48
1.25
0.20
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
48
1.25
0.20
1.3
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
29.6
—
0
14
(3036670) Protein [Mass/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.1
—
37.4
—
0
9
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
108
1.21
0.20
1.8
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
49
1.23
0.20
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
165
1.16
0.19
1.5
1.1
iu/ml
67.3
136.9
—
7
57
(3026389) Candida sp identified in Specimen by Organism specific culture
6
52
1.16
0.19
1.5
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
53
1.13
0.18
1.7
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
340
0.91
0.17
5.3
6.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
148
1.15
0.17
1.3
2.0
—
—
—
0
0
(3000492) Spirometry study
30
273
1.11
0.16
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
13
150
0.86
0.15
2.4
2.0
ug/l
230.3
626.5
0.66
13
140
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
72
755
0.94
0.14
3.9
3.2
ug/l
1.0
0.8
0.27
59
527
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
110
1062
1.05
0.14
5.3
4.7
%
23.0
21.7
0.45
61
542
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
489
0.93
0.13
7.2
8.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
53
502
1.06
0.13
5.0
6.5
kpa
5.0
5.1
0.49
48
481
(3027801) Oxygen [Partial pressure] in Arterial blood
53
503
1.06
0.12
5.0
6.4
kpa
12.2
11.5
0.44
48
483
(3020891) Body temperature
19
175
1.09
0.08
3.1
4.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
88
1.14
0.08
1.0
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
35
368
0.95
0.08
2.7
5.9
mmol/l
1.3
1.4
0.52
30
346
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
67
1.05
0.08
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
81
0.86
0.07
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
334
1.05
0.07
3.8
3.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
87
1.04
0.07
1.4
1.7
mg/l
8.0
14.2
—
9
78
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
502
1.04
0.07
2.5
1.8
—
—
—
0
0
(1002224) Polysomnography panel
9
88
1.02
0.07
1.2
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
658
0.97
0.06
4.2
3.1
e6/l
3.6
2.6
0.39
44
373
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
110
0.91
0.05
1.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
49
503
0.97
0.04
2.6
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
129
0.93
0.03
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
127
0.94
0.01
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
277
0.97
0.01
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
125
0.96
0.00
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
136
1.03
0.00
3.9
4.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
246
1.02
0.00
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
157
1.02
0.00
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
222
0.99
0.00
2.2
2.6
—
12.9
—
0
9
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
91
906
1.01
0.00
2.4
2.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
99.4
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
21.4
—
1734.9
—
0
8
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
112.8
—
0
5
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.4
—
0.6
—
0
5
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
129.8
—
0
5
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
18.0
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
19.5
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
12.6
—
987.9
—
0
8
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
80
1.00
0.00
1.4
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
93
0.97
0.00
1.2
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
93
0.97
0.00
1.2
1.3
—
—
—
0
0
(4094501)
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
78.4
—
0
7
(3019230) Fractional oxyhemoglobin in Venous blood
7
70
1.00
0.00
2.3
1.6
%
71.7
62.1
—
7
70
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
1.8
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
64
0.94
0.00
1.5
1.1
u/l
8.1
44.1
—
6
54
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_NONIONRADISKINNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_NONIONRADISKINNAS | 0.839 [0.75, 0.94] | 0.003 |
| Birth year | 0.995 [0.99, 1.0] | 0.298 |
During the follow-up period (1.1.1998 — 31.12.2019), 659 out of 1855 females with L12_NONIONRADISKINNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_NONIONRADISKINNAS | 0.902 [0.79, 1.03] | 0.133 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 578 out of 1306 males with L12_NONIONRADISKINNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_NONIONRADISKINNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.097% | 0.162% |
| 5 | 0.522% | 0.98% |
| 10 | 1.337% | 2.459% |
| 15 | 2.522% | 4.826% |
| 20 | 4.316% | 8.193% |
Relationships between endpoints
↥Index endpoint: L12_NONIONRADISKINNAS – Other and unspecified skin changes due to chronic exposure to nonionizing radiation
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data